Position in CDXS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$131,532
+$12,912 QoQ
Shares Held
58,200
+128.6% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 148 holders
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $623,499,718 across 77 Biotechnology names. CDXS ranks #74 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
175,291 | $109,300,950 | |
| 2 | INCY |
Incyte Corp
|
881,889 | $99,970,937 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
664,031 | $40,080,911 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
337,461 | $39,506,559 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
490,724 | $27,878,030 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
104,935 | $25,286,186 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
1,291,182 | $24,158,015 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
572,538 | $21,304,138 |
All Filings in CDXS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $131,532 | 58,200 | Shares | Sole | 2026-08-06 | |
| 2022-12-31 | $118,620 | 25,455 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $161,535 | 26,656 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $259,094 | 24,770 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $510,757 | 24,770 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $774,557 | 24,770 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $292,122 | 12,559 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $284,586 | 12,559 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $350,926 | 15,331 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||